Clinical Trial

LUpus Eritematoso Sistemico NETwork and Registry

Study acronym: LUNET
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The LUNET Registry is intended to serve as a comprehensive primary data source, capturing real-world longitudinal clinical information, and the heterogeneity of patient presentations that are often underrepresented in traditional clinical trials. Ultimately, the LUNET Registry will help to optimize SLE management in routine clinical practice by enabling the compilation of real-world evidence to inform clinical decision-making and health policy. Patients will be enrolled by secondary and tertiary care centres for SLE across Italy in a real-world clinical set-up.
Trial Details
NCT Number NCT07175610
Lead Sponsor Società Italiana di Allergologia, Asma e Immunologia Clinica
Conditions Systemic Lupus Erythematous (SLE)
Enrollment 1,500 participants
Start Date 2025-09-30
Primary Completion 2026-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-16